NovoCure (NVCR) Launches 12.5M Common Stock IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
NovoCure Limited (Nasdaq: NVCR) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO
October 2, 2015 6:00 AM UTCADVISORY, Oct. 02, 2015 (GLOBE NEWSWIRE) --
What:Â
NovoCure Limited (Nasdaq: NVCR), a commercial stage oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO).
In honor of the occasion, Asaf Danziger, Chief Executive Officer and Bill Doyle, Executive Chairman will ring the Opening Bell.Â
Where:
Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:
Friday, October 2, 2015 9:15 a.m. to 9:30 a.m. ETÂ Â Â Â Â Â Â
NovoCure... More
NovoCure Limited (Nasdaq: NVCR) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO
October 2, 2015 6:00 AM UTCADVISORY, Oct. 02, 2015 (GLOBE NEWSWIRE) --
What:Â
NovoCure Limited (Nasdaq: NVCR), a commercial stage oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO).
In honor of the occasion, Asaf Danziger, Chief Executive Officer and Bill Doyle, Executive Chairman will ring the Opening Bell.Â
Where:
Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:
Friday, October 2, 2015 9:15 a.m. to 9:30 a.m. ETÂ Â Â Â Â Â Â
NovoCure... More
NovoCure Limited Announces Launch of Initial Public Offering
October 1, 2015 9:07 PM UTCST. HELIER, Jersey--(BUSINESS WIRE)-- NovoCure Limited, a commercial stage oncology company pioneering a novel therapy for solid tumors, announced today the launch of its initial public offering of 12,500,000 shares of its common stock, including 7,500,000 shares to be sold by NovoCure Limited and 5,000,000 shares to be sold by selling shareholders. The initial public offer is currently expected to be between $26 and $29 per share. The underwriters for the offering will also have a 30-day option to purchase up to an additional 1,875,000 ordinary shares from the selling shareholders. NovoCure Limited has applied to list its common stock on the NASDAQ... More
